The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study

被引：0
|
作者：
Selwyn van Rijn
Bark Betzel
Charlotte de Jonge
David P. J. van Dijk
Ignace M. Janssen
Frits J. Berends
Nicole D. Bouvy
Jan Willem M. Greve
机构：
[1] Maastricht University Medical Center,Department of General Surgery
[2] Rijnstate Medical Center,Department of General Surgery
[3] Zuyderland Medical Center,Department of General Surgery
来源：
Obesity Surgery | 2018年 / 28卷
关键词：
Obesity; Abdominal surgery; Duodenal-jejunal bypass liner; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1255 / 1262
页数：7
相关论文
共 50 条
  • [21] Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis
    Chen, Wenhui
    Feng, Jia
    Dong, Shiliang
    Guo, Jie
    Zhou, Fuqing
    Hu, Songhao
    Hu, Ruixiang
    Wang, Cunchuan
    Ma, Yi
    Dong, Zhiyong
    OBESITY REVIEWS, 2024, 25 (11)
  • [22] The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
    Ruban, Aruchuna
    Ashrafian, Hutan
    Teare, Julian P.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [23] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients
    Rodrigo Muñoz
    Alex Escalona
    Current Cardiology Reports, 2014, 16
  • [24] WHAT HAPPENS TO WEIGHT AND TYPE 2 DIABETES AFTER EXPLANTATION OF THE DUODENAL-JEJUNAL BYPASS LINER?
    Betzel, Bark
    Homan, Jens
    Schijns, Wendy
    Deden, Laura
    van Rens, Michiel
    Aarts, Edo
    Janssen, Ignace
    Wahab, Peter
    Groenen, Marcel
    Berends, Frits
    OBESITY SURGERY, 2015, 25 : S55 - S56
  • [25] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitusin Morbidly Obese Patients
    Munoz, Rodrigo
    Escalona, Alex
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (03)
  • [26] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
  • [27] ENDOSCOPICALLY DELIVERED DUODENAL-JEJUNAL BYPASS LINER TO TREAT TYPE 2 DIABETES IN OBESE PATIENTS
    Curcio, G.
    Casu, A.
    Traina, M.
    Colanino, M. Ziino
    Tuzzolino, F.
    Vizzini, G.
    Gridelli, B.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S143 - S143
  • [28] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    Charlotte de Jonge
    Sander S. Rensen
    Hedwig M. A. D’Agnolo
    Nicole D. Bouvy
    Wim A. Buurman
    Jan Willem M. Greve
    Obesity Surgery, 2014, 24 : 337 - 341
  • [29] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    de Jonge, Charlotte
    Rensen, Sander S.
    D'Agnolo, Hedwig M. A.
    Bouvy, Nicole D.
    Buurman, Wim A.
    Greve, Jan Willem M.
    OBESITY SURGERY, 2014, 24 (02) : 337 - 341
  • [30] THE DUODENAL-JEJUNAL BYPASS SLEEVE (ENDOBARRIER GASTROINTESTINAL LINER) FOR WEIGHT LOSS AND TREATMENT OF TYPE II DIABETES
    Patel, S.
    Hakim, D.
    Mason, J.
    Hakim, N.
    GUT, 2013, 62 : A159 - A159
12345